Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H5 antigens, respectively, were generated and characterized. Enzyme immunoassays and immunoblots demonstrated that MAb 2C5-F10 reacted specifically with lipopolysaccharide O antigen of E. coli O4 isolates, while MAb 8D1-H10 reacted with E. coli strains expressing H5 flagella.
munized with E. coli O4:K3:H5 (E. coli Reference Center [ECRC] U4-41, the O4 and H5 reference strain) (20) wholebacterium lysate and boosted with semipurified H5 flagellin (12) . Immunization, hybridoma and ascites production, and MAb screening, isotyping, and characterization protocols were as previously described (12, 21) . One anti-E. coli O4 MAb (2C5-F10; immunoglobulin M [IgM] isotype) and one anti-H5 MAb (8D1-H10; IgG1 isotype) were generated and characterized. MAb diagnostic sensitivity and specificity were estimated by enzyme-linked immunosorbent assay (ELISA) reactivity with whole-bacterium lysate preparations from 350 antigenically diverse gram-negative bacterial (272 E. coli and 78 non-E. coli) strains. The E. coli subset consisted of 8 O4:H5 strains, 4 O4:non-H5 strains, 8 non-O4:H5 strains, and 252 non-O4: non-H5 (including 1 non-O4:H autoagglutinable [ Fig. 1 . CRX, non-E. coli H5 bacteria known to cross-react with anti-E. coli H5 PAb; *, datum point for E. coli O2:HA (autoagglutinable) 92-0609, which was presumptively H5 based on Western immunoblotting (Fig. 4) . Data for MAb ELISA reactivity with 78 non-E. coli isolates are not shown.
lates (sensitivity, 100%; 95% CI, 73.5 to 100) and nonreactive with 260 non-O4 E. coli and 78 non-E. coli isolates (specificity, 100%; 95% CI, 98.9 to 100) ( Fig. 1) . Significantly, there was no MAb ELISA reactivity with 12 bacteria that cross-react with anti-O4 PAb.
MAb 8D1-H10 reacted with 13 of 16 E. coli H5 isolates (sensitivity, 81.3%; 95% CI, 54.4 to 96.0) (Fig. 2) ; the three nonreactive strains were E. coli O75:H5 isolates. In spite of repeated attempts to induce and select for motility using flagellum broth and semisolid motility agar (12), these three strains remained nonmotile in our laboratory both macroscopically in media and microscopically under phase-contrast microscopy. This suggests that these E. coli O75:H5 strains may have been nonreactive with the anti-H5 MAb due to lack of expression of flagellar antigens (12) . This MAb did not react with 78 non-E. coli strains but reacted with 1 of 255 non-H5 E. coli (specificity, 99.6%; 95% CI, 97.9 to 99.9) strains (Fig. 2) .
The cross-reactive strain was E. coli O2:HA (ECRC 94-0609), which possesses an unknown H-antigen.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western immunoblotting using whole-bacterium lysates, semipurified flagellin, and LPS preparations from E. coli O4 and H5 and non-O4 and non-H5 antigens confirmed MAb O4 and H5 specificity (12, 21) (Fig. 3  and 4) . Reactive bands from gels transferred onto polyvinylidene difluoride membranes and incubated with MAb were revealed with HRP-conjugated rabbit anti-mouse IgGϩIgM and diaminobenzidine substrate. The ladder pattern characteristic of LPS was observed on silver-stained gels and membranes incubated with anti-O4 MAb 2C5-F10 (Fig. 3) , which reacted only with E. coli O4:H5 (lanes 1 to 3) and O4:H32 (lane 4), but not with four other whole-bacterium preparations (Fig. 3B) . Similar results were obtained using semipurified LPS as antigen (data not shown). Specificity of MAb 8D1-H10 for H5 antigen was confirmed by SDS-PAGE of semipurified flagellins and whole-bacterium preparations followed by immunoblotting (Fig. 4) . MAb 8D1-H10 reacted predominantly with purified flagellins (lane 3) and whole-bacterium preparations (lanes 4, 5, and 8) of E. coli H5 at the expected molecular mass of 46 kDa (17) . MAb 8D1-H10 immunoblotting of ELISA-reactive E. coli O2:HA 94-0609 produced a doublet of reactive bands at M r of Ϸ46 and Ϸ37 kDa. The 46-kDa reactive band of this autoagglutinable strain was of a size consistent with H5 flagellin; the 37-kDa band could be an H5 degradation product or a non-H5 flagellin.
To validate MAb performance, a second panel of 37 E. coli O4, H5, non-O4, and non-H5 human clinical isolates (kindly provided by J. R. Johnson, University of Minnesota, St. Paul) was tested blindly for ELISA reactivity separately with each MAb (Table 1 ). The anti-O4 MAb reacted with 11 of 12 E. coli O4 strains and with 0 of 25 non-O4 strains. The nonreactive E. coli O4:H-multiple strain Z was serotyped as O82:H-multiple when submitted to the ECRC after MAb ELISA testing. The anti-H5 MAb reacted only with the four E. coli H5 strains.
In conclusion, we produced MAb against the E. coli O4 and H5 antigens that appeared to be sensitive and specific as assessed by ELISA and immunoblotting. These MAb have potential clinical use as immunodiagnostic or serotyping reagents, especially if used in combination with other phenotypic or genotypic pathogenicity markers. They may be of particular utility for experimental or epidemiologic studies of extraintestinal E. coli O4:H5 infections.
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